[{"Assets_0_Q1_USD":250873000.0,"CommonStockSharesOutstanding_0_Q1_shares":89622626.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-66811000.0,"NetIncomeLoss_1_Q1_USD":-67904000.0,"StockholdersEquity_0_Q1_USD":79567000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20190630","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190806"}]